SIMPLE/LITAF Expression Induces the Translocation of the Ubiquitin Ligase Itch towards the Lysosomal Compartments by Eaton, Heather E. et al.
SIMPLE/LITAF Expression Induces the Translocation of
the Ubiquitin Ligase Itch towards the Lysosomal
Compartments
Heather E. Eaton
1., Guillaume Desrochers
2., Samuel B. Drory
2, Julie Metcalf
1¤, Annie Angers
2", Craig R.
Brunetti
1*
1Department of Biology, Trent University, Peterborough, Canada, 2De ´partement de Sciences Biologiques, Universite ´ de Montre ´al, Station ‘Centre-Ville’, Montre ´al, Canada
Abstract
LITAF is a small cellular protein with an unknown function. The C-terminus of LITAF contains a highly conserved domain
termed the SIMPLE-like domain (SLD), while the N-terminus contains two PPXY motifs that mediate protein-protein
interactions with WW-domain containing proteins. LITAF also harbors two endosome/lysosome targeting sequences at its
C-terminus, but there has been conflicting reports regarding its intracellular localization. Here, we demonstrate that LITAF is
localized to the late endosome/lysosomal compartment in a variety of cell lines. We also show that Itch, a WW-domain
containing protein, and LITAF strongly interact and that this interaction depends on the two PPXY motifs in the N-terminus
of LITAF. Interestingly, co-expression of LITAF with Itch induces major changes in Itch intracellular localization, bringing Itch
from the trans-Golgi network to lysosomes. We show that this re-localization is dependent upon the interaction with the
PPXY sequences of LITAF, since disruption of these binding motifs completely abrogates Itch re-localization.
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Introduction
LITAF (lipopolysaccharide-induced tumor necrosis factor-alpha
factor), also known as SIMPLE (small integral membrane protein
of the lysosome/late endosome) and PIG-7 (p53 inducible gene-7)
was first identified as a gene that was up-regulated in response to
bacterial cell wall components, including lipopolysaccharide (LPS),
and was therefore proposed to be a pathogen-associated molecular
pattern (PAMP)-inducible gene [1,2,3]. LITAF is predicted to
encode a 161 amino acid protein. The N-terminus of LITAF
contains two PPXY (PY) motifs responsible for binding to WW
domain oxidoreductase (WWOX), neuronal precursor cell ex-
pressed developmentally downregulated 4 (Nedd4), and tumor
suppressor gene 101 (TSG101) [4,5,6]. The C-terminus of LITAF
is 68 amino acids long and contains a modified RING-finger
domain composed of a CX2C motif, a long (approximately 25
amino acid) hydrophobic region, and a HXCX2C motif. This
interrupted RING-finger has been termed the SIMPLE-like
domain (SLD) [1]. This domain is found in a wide range of
species (including yeast, plants, insects, and humans) and
represents a new family of proteins with unknown function [1].
Other functions that have been ascribed to LITAF [2,7,8,9] have
been called into question with evidence from a number of groups
suggesting that the LITAF used in these experiments contained a
nucleotide insertion that altered the reading frame in the C-
terminal half of the protein, thereby eliminating the SLD
[1,10,11].
In addition to the SLD, the C-terminus of LITAF contains the
carboxyl terminus lysosomal targeting sequence YXXW (where W
is any bulky hydrophobic amino acid) [1]. Currently, the
localization of LITAF remains unclear and may be cell type
specific [6]. LITAF has been found to localize to late endosomes/
lysosomes [1], the Golgi apparatus [5,6], and to the plasma
membrane [6]. Although cellular localization of LITAF is
inconsistent, it does appear that LITAF localizes along secretory
and lysosomal degradation pathways.
There are several lines of evidence that suggest that LITAF may
function in protein degradation. First, E3 ubiquitin ligases, which
are involved in ubiquitin-mediated degradation of proteins, often
contain RING-finger domains [6,12,13]. LITAF contains a
modified RING-finger domain. However, it is not clear how the
hydrophobic amino acids present within the RING-finger domain
of LITAF affect its function. Second, LITAF mutations are
associated with Charcot-Marie-Tooth (CMT) disease [10,14,15].
CMT is an inherited peripheral neuropathy that can be
characterized by protein aggregates [16], suggesting a putative
role for LITAF in protein degradation. Last, binding partners of
LITAF, including Nedd4 and TSG101, are involved in lysosomal
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containing E3 ubiquitin ligases. This family of proteins shares a
common structure, which includes an N-terminal C2 domain, 2–4
WW domains, as well as a C-terminal HECT domain. Nedd4 acts
at the plasma membrane and the Golgi apparatus to mono-
ubiquitinate substrates for degradation in the lysosome [17].
TSG101, another binding partner of LITAF [6], operates
downstream of Nedd4. TSG101 acts to recognize and sort
mono-ubiquitinated substrates into multivesicular bodies for future
lysosomal degradation [18,19].
The interaction between LITAF and Nedd4 or WWOX is
mediated by PPXY motifs found in the N-terminus of LITAF [4].
Itch is another member of the Nedd4/Nedd4-like HECT E3
family that binds to PPXY motifs via its WW domains. Itch, a
homologue of the human atrophin-1-interacting protein 4 (AIP4),
was first identified as a gene disrupted in non-agouti-lethal 18H
mice that develop a spectrum of immunological diseases and
constant itching of the skin [20]. The Itch gene encodes an 864
amino acid protein that regulates important cellular functions by
inducing proteasomal degradation of a variety of substrates. As it is
demonstrated by the a
18H phenotype, Itch plays a role in the
immune response by binding c-jun and JunB via its WW domains.
Itch induces ubiquitination and degradation of these transcription
factors involved in TH2 differentiation, providing a molecular link
between Itch deficiency and the itching phenotype [21]. Itch’s
WW domains also bind to a PPPY motif in the C-terminus of p73,
inducing its ubiquitination and degradation. This transcription
factor is involved in the response to DNA damage and in cell cycle
control, providing another role for the ligase [22]. Furthermore,
the implications of Itch also extend to cell death by promoting c-
FLIP turnover, an anti-apoptotic protein inhibiting caspase-8 [23].
Itch also acts as a key molecule between EGF signaling and cell
survival through downregulation of tBid, an important interme-
diate in ligand-induced apoptosis via caspase-3 activation [24].
Itch does not only affect receptor signaling, but can also influence
EGFR stability at the plasma membrane by controlling the
expression of Cbl and Endophilin, two trafficking proteins
required for receptor endocytosis [25].
The Itch ligase localizes to the trans-Golgi network and to
endosomal compartments, which confers the capacity to interact
with internalized proteins and their endocytic accessory proteins
and cause their proteasomal degradation, which affects protein
trafficking [26]. Similar to Itch, LITAF has also been reported to
localize to late endosomes [1], raising the possibility that these
proteins may interact in vivo and influence each other’s activity.
Here, we report that Itch strongly interacts with LITAF, and
that this interaction relies on the WW domains of Itch and on the
two PPXY motifs found in the N-terminus of LITAF. Interest-
ingly, co-expression of LITAF with Itch induces major changes in
Itch intracellular localization, bringing Itch to the lysosome. We
show that this re-localization is dependent upon the interaction
with LITAF, since disruption of the binding motifs completely
abrogates Itch re-localization. In contrast, although Nedd4 also
interacts with LITAF, it is not re-localized upon expression of
LITAF.
Results
LITAF interacts with Itch
LITAF is known to interact via its PY motifs with the WW
domains of Nedd4, an ubiquitin ligase of the C2-WW-HECT
family, and this interaction occurs at the plasma membrane and
Golgi apparatus [4,6]. All ligases of this family have highly
homologous WW domains and are able to bind PY motifs. Of
these, Itch presents an intracellular localization with enrichment in
Golgi/endosomal compartments, displaying potential overlapping
localization with LITAF [1,26,27]. Therefore, one could expect
that LITAF and Itch will interact. To verify this hypothesis, we
transfected HEK-293T cells with myc-LITAF in the presence or
absence of FLAG-Itch. We then immunoprecipitated transfected
cell extracts with a monoclonal antibody against FLAG and looked
for the presence of myc fusion proteins in the immunoprecipitated
fractions. When FLAG-Itch was immunoprecipitated we were able
to detect myc-LITAF by Western blot, demonstrating the
interaction between Itch and LITAF (Figure 1A). We then refined
these results using pull-down assays to determine which domain of
Itch is involved in the binding. Wild-type myc-LITAF expressed in
HEK-293T cells specifically bound to GST-fusion proteins of full-
length Itch and the isolated WW domains of Itch, but failed to
interact with GST alone or the GST-fused PRD domain of Itch.
This experiment confirmed that the WW domains of Itch are
sufficient to mediate the interaction with LITAF (Figure 1B).
GST-fusion proteins are shown in the Ponceau staining below the
immunoblot. Note that the GST-Itch-WT fusion is showing
several degradation bands, as typically seen with this particular
fusion protein (e.g., [28]).
To determine if the interaction occurred in living cells, we used
bioluminescent resonance energy transfer (BRET) using HEK-
293T cells co-transfected with Itch fused to Renilla luciferase
(rLuc-Itch) and GFP-LITAF. Coelenterazine degradation by rLuc
generates non-radiative resonance energy that is transferred from
the emitting rLuc to GFP, which becomes excited and in turn
emits fluorescence when rLuc and GFP are in close proximity
(#100 Au) as a consequence of fusion protein interaction. A BRET
ratio is calculated for each transfection condition, as detailed in
Materials and Methods. A significant BRET signal was measured
only in cells co-transfected with rLuc-Itch and GFP-LITAF,
whereas only a background-level signal was generated by cells co-
transfected with rLuc-Itch and GFP (Figure 1C). This figure shows
a representative example of an increasing BRET ratio with
increased GFP fusion expression, whereas rLuc was kept relatively
constant. Similar results were obtained with rLuc-LITAF and
GFP-Itch (not shown). These results together confirm that LITAF
and Itch interact in living cells.
LITAF localizes to late endosomes/lysosomes
We then confirmed the subcellular localization of LITAF, since
there is discrepancy in the literature about its localization and it is
suggested to be cell type specific [6]. Due to the fact that
endogenous LITAF levels are below detection, we transiently
transfected FLAG-LITAF or myc-LITAF into BGMK cells at
different time points. At all time points we observed strong
vesicular staining throughout the cytoplasm, which localized with
the late endosome/lysosome marker LysoTracker, but not with
the trans-Golgi network marker IGF-IIR (Figure 2A). Similar
results were seen in HEK-293T, Cos-7 cells, and PAE cells
(Supporting figure S1). This demonstrates that LITAF localizes to
late endosomes/lysosomes in several cell lines.
Subcellular localization of Itch is altered by the presence
of LITAF
In order to determine the extent of Itch and LITAF overlap in
their subcellular localization, we first examined Itch localization in
BGMK and HEK-293T cells. FLAG or GFP-Itch was transfected
into cells that were then probed with LysoTracker or IGF-IIR. As
previously demonstrated [26], we found extensive co-localization
between Itch and a marker of the trans-Golgi network (IGF-IIR),
but no co-localization with LysoTracker, a late endosome/
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Itch and LysoTracker, as well as between FLAG-LITAF and IGF-
IIR (Figure 2A and B), suggesting that both proteins do not reside
in the same compartment. Surprisingly, when FLAG-LITAF was
transiently co-transfected along with GFP-Itch, LITAF and Itch
were found to co-localize within the cell along with LysoTracker
and not with IGF-IIR (Figure 3). This data suggests that LITAF is
able to alter the cellular localization of Itch from the trans-Golgi
network to the lysosomes.
Two PPXY motifs in LITAF are required for the interaction
between Itch and LITAF
Interactions between Itch and substrate proteins occur via Itch’s
WWdomains.TheWWdomainsrecognizeand bindtoprolinerich
PY domains, including PPXY motifs. LITAF contains two PPXY
motifs within its N-terminus and while Itch is suspected to bind to
LITAF through these PPXY elements, it is unclear whether a single
PPXY motif or both PPXY motifs are required for binding. Using
site-directed mutagenesis the PPXY motifs of LITAF were mutated
to PPXA, which abolishes binding to WW domains [29]. Three N-
terminal GFP-tagged LITAF constructs were generated. We then
conducted pull-down assays using these constructs and GST-Itch to
determine the interaction between Itch and the mutated forms of
LITAF. When both PPXY sites were mutated, LITAF did not
interact with any Itch domain, demonstrating the WW domain
binding to PPXY motifs is the only interaction site between the two
proteins (Figure 4A). However, LITAF-WT and both of the single
PY mutants expressed in HEK-293T cells strongly bound to the
WW domains of Itch fused to GST (Figure 4B). The double mutant
alone was unable to bind the GST-fused WW domains of Itch
(Figure 4B). This experiment shows that the mutation of a single PY
motif of LITAF is not sufficient to disrupt the interaction with Itch.
On the other hand, the mutation of both PY motifs completely
abolished the interaction (Figure 4B). Similar results were obtained
in living cells using BRET, where disruption of a single PPXY motif
mutation did not significantly alter the binding of LITAF to Itch,
but the double mutant completely lost all BRET signal (Figure 4C).
To determine if both binding sites contributed equally, we
performed a quantitative experiment to compare binding of the
different forms of LITAF to Itch WW domains. Densitometry
Figure 1. LITAF interacts with Itch in vitro and in vivo. (A) HEK-293T cells were transiently transfected with FLAG-Itch with or without co-
transfection of myc-LITAF. Total cell lysates were blotted with anti-FLAG and anti-myc to show protein expression (lower panel), and
immunoprecipitated with anti-FLAG to reveal LITAF co-immunoprecipitation (upper panel). (B) Extracts from 293T cells transfected with myc-LITAF
were incubated with either GST alone, GST-Itch WT, GST-Itch PRD or GST-Itch WW pre-coupled to glutathione-Sepharose. Input proteins is shown in
the first lane (CL). Proteins bound to GST beads are shown in the next lanes. Immunoblotting with anti- myc antibodies shows the presence of myc-
LITAF (upper panel). Total gel loading is shown by ponceau staining of the blot to reveal GST loading. The bands representing the GST-fusions in the
Ponceau staining are marked by a red asterisk. Additional staining in the GST-Itch-WT lane likely represents degradation products of the fusion
protein. (C) 293T cells were co-transfected with constant amount of rLuc-Itch and various amounts of either GFP alone or GFP-LITAF. The graph is a
representative example of the saturation studies performed to provide evidence for a specific interaction between the proteins. BRET ratios were
plotted as a function of the excited GFP activity to total rLuc activity ratio, allowing comparison of BRET ratios between the negative control GFP and
GFP-LITAF when expressed at the same level.
doi:10.1371/journal.pone.0016873.g001
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LITAF-Y23A slightly decreased binding, the mutation of LITAF-
Y61A had no significant effect compared to WT. As demonstrated
before, mutation of both tyrosines completely abolished Itch
binding (Figure 4D). These results show that Itch WW domains
can recognize both PY motifs with a small preference towards the
first PPXY motif. However, the loss of a single binding site is not
sufficient to prevent binding.
Figure 2. LITAF and Itch cellular localization. BGMK cells were transiently transfected for 8 or 24 hours with (A) FLAG-LITAF or (B) GFP-Itch. Live
cells were initially incubated with LysoTracker followed by fixation and permeabilization. Cells then underwent indirect immunofluorescence using
anti-IGF-IIR (trans Golgi-network; blue) and/or anti-FLAG antibodies (LITAF; red). GFP-Itch is shown in green. Differential interference contrast (DIC)
was used to visualize cells and images were captured using a laser scanning confocal microscope.
doi:10.1371/journal.pone.0016873.g002
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interaction with LITAF
Since both LITAF PPXY motifs are able to interact with Itch,
we next tested the LITAF mutants for their ability to alter the
localization of Itch (Figure 5A). When GFP-LITAF-Y23A was
transiently co-transfected into cells with FLAG-Itch, it was found
that some co-localization remained between LITAF and Itch, and
that staining overlapped with LysoTracker (Figure 5B). Transient
transfection of GFP-LITAF-Y61A along with FLAG-Itch showed
high levels of co-localization between LITAF and Itch (Figure 5B).
The overlap between LITAF-Y61A and Itch showed co-
localization with LysoTracker (Figure 5B). When the LITAF
double mutant (GFP-LITAF-Y23,61A) was transfected into
BGMK cells along with FLAG-Itch, no overlap was found
between LITAF Y23,61A and Itch (Figure 5B). LITAF-Y23,61A
localized along with LysoTracker suggesting that mutation of
either PPXY motif has no effect on the subcellular localization of
LITAF (Figure 5B). While LITAF-Y23,61A remained localized to
the lysosome, Itch remained co-localized with the marker IGF-IIR
suggesting that the interaction between Itch and LITAF is critical
for the re-localization of Itch upon LITAF expression. Disruption
of LITAF PPXY motifs abolished the interaction with Itch.
We next sought to determine if the endogenous Itch protein was
equally susceptible to LITAF-induced relocalization as overex-
pressed FLAG-Itch. We used COS-7 cells, HEK-293-T cells and
PAE cells grown on glass coverslips and transfected with either
GFP-LITAF-WT or GFP-LITAF-Y23,61A. In non-transfected
cells, anti-Itch staining is visible throughout the cytoplasm, with
concentration in areas near the trans-Golgi network and
endosomal compartments. Endogenous Itch localization, although
more diffused, is similar to overexpressed FLAG or GFP-Itch. In
cells expressing GFP-LITAF-WT, we observe a significant
accumulation of Itch in GFP-LITAF-WT-rich puncta. Colocaliza-
tion of Itch and LITAF-WT can be observed in all examined cell
lines (Supporting figure S1). In contrast, overexpression of GFP-
LITAF-Y23,61,A does not alter Itch distribution as compared to
non-transfected cells, or cell transfected with GFP only (Support-
ing figure S1).
LITAF is unable to alter the cellular localization of Nedd4
Since LITAF causes the relocation of Itch, we wanted to
determine if LITAF caused relocation of other WW domain
containing proteins. Nedd4 is a WW domain containing E3
ubiquitin ligase that has previously been shown to interact with
LITAF [4,6]. YFP-Nedd4 was transiently transfected and the
Nedd4 protein was found localized to the perinuclear region, the
plasma membrane, and also exhibited some cytoplasmic vesicular
staining (Figure 6). Staining in the perinuclear region of the cell co-
localized strongly with the Golgi marker, Golgin 97 (Figure 6). Co-
transfection of myc-LITAF and YFP-Nedd4 into BGMK cells
resulted in some, but not complete, co-localization between the
two proteins (Figure 6). While some overlap was present, LITAF
remained localized to the late endosomes/lysosomes while Nedd4
localization remained consistent with the expression pattern when
Nedd4 was transfected alone (Figure 6). To determine if the PPXY
motifs of LITAF affected Nedd4 localization, YFP-Nedd4 was also
transiently co-transfected with the LITAF double mutant (myc-
LITAF Y23A,61A). There was no change in localization of Nedd4
when co-transfected with the double mutant (Figure 6). Nedd4
remained localized to the Golgi with a small amount of
localization with LITAF/lysosomes. This highlights that the
behavior of Nedd4 is different from that of Itch in the presence
of LITAF. This suggests that the ability of LITAF to interact with
and alter the cellular localization of Itch is unique and not a
common feature to other WW domain containing proteins.
Discussion
Here we describe a novel interaction between LITAF and the
ubiquitin ligase Itch. This interaction resulted in a change of
cellular localization of Itch from the trans-Golgi network to
lysosomes, where it co-localized with LITAF. The interaction is
specific and cellular re-localization was mediated through Itch’s
WW domains and the two PPXY motifs found in the N-terminus
of LITAF.
The function of LITAF is currently unknown, although many
pieces of evidence, including the ability of LITAF to interact with
Nedd4 and TSG101, point to a role in the ubiquitin-mediated
Figure 3. LITAF changes the cellular localization of Itch. FLAG-LITAF was transiently co-transfected into BGMK cells with GFP-Itch. Sixteen
hours post-transfection, cells were probed with LysoTracker (blue) and fixed. LITAF was detected using anti-FLAG antibodies (red) while the trans-
Golgi network was identified using anti-IGF-IIR antibodies (blue). GFP-Itch is shown in green. Cells were visualized using DIC.
doi:10.1371/journal.pone.0016873.g003
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ligase that contains several WW domains that interact with PPXY
containing proteins and catalyzes ubiquitination through a
catalytically active HECT domain. Ubiquitinated proteins then
interact with TSG101, a vascular protein sorting (Vps) protein that
binds to and sorts ubiquitinated proteins at the endosomal
membrane [18,19]. The interaction between TSG101 and
substrate proteins is mediated through a proline rich P(S/T)AP
motif.
In this study we demonstrated that LITAF not only binds to
Nedd4 and TSG101, but also the E3 ubiquitin ligase Itch.
Independently, Itch and LITAF localize to different compartments
within the cell, specifically Itch localizes to the trans-Golgi network
and LITAF localizes to late endosomes/lysosomes. Although
endogenous LITAF could not be detected in our cell lines,
overexpressed LITAF localized to lysosomes at 8 hours post-
transfection suggesting that even at low levels LITAF is localized to
lysosomes. This fact, along with previous localization of LITAF to
the lysosome and the presence of a lysosomal targeting sequence in
the C-terminus of LITAF suggests that the lysosomal localization of
overexpressed LITAF is reliable [1]. In order for Itch and LITAF to
interact they must localize, at least transiently, within the same
compartment of the cell. The ubiquitin-mediated lysosomal
degradation pathway is very dynamic and the trans-Golgi network,
endosomes (early and late), and lysosomes are intricately linked with
proteins shuttling rapidly from one location to another. It is highly
likely then that Itch and LITAF are at least transiently within the
same cellular compartment. However, LITAF must have a
Figure 4. Mutation of both PPXY domains disrupts Itch and LITAF interaction. (A) Extracts from HEK-293T cells transfected with GFP-LITAF
WT or GFP-LITAF Y23,61A were incubated with either GST alone, GST-Itch WT, GST-Itch PRD or GST-Itch WW pre-coupled to glutathione-Sepharose.
Aliquot from total cell lysate (CL) and proteins specifically bound to the beads were processed by immunoblot with a polyclonal antibody against
GFP. (B) HEK-293T cells were transiently transfected with either GFP-LITAF WT, GFP-LITAF Y61A, GFP-LITAF Y23A or GFP-LITAF Y23,61A. Aliquots of CL
were processed by immunoblot with GFP antibody to show protein expression. The rest of the extracts were incubated with either GST or GST-Itch
WW fusion proteins pre-coupled to gluthatione-Sepharose. Proteins specifically bound to the beads were immunoblotted with GFP antibody to
reveal protein interactions. The bands representing the GST-fusions in the Ponceau staining are marked by a red asterisk. Additional staining in the
GST-Itch-WT lane likely represents degradation products of the fusion protein. (C) 293T cells were co-transfected with constant amount of rLuc-Itch
and various amounts of either GFP-LITAF Y61A or GFP-LITAF Y23,61A. The graph is a representative example of the saturation studies performed to
provide evidence for a specific interaction between the proteins. BRET ratios were plotted as a function of the excited GFP activity to total rLuc
activity ratio, allowing comparison of BRET ratios between GFP-LITAF Y61A and GFP-LITAF Y23,61A when expressed at the same level. (D)
Quantification of the interaction between Itch WW domains and the different LITAF constructs. The densitometry of GFP signal in the fraction bound
to GST-Itch-WW beads relative to the densitometry of the GFP signal in 1/10 volume of protein extract is represented as described in materials and
methods. Data are mean 6 s.e.m. from n=4 experiments. * p,0.05 compared to binding of GFP-LITAF WT (ANOVA post-hoc Tukey).
doi:10.1371/journal.pone.0016873.g004
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network and into the late endosome/lysosome compartment.
Interestingly, the interaction between LITAF and Itch may suggest
a potential orientation for LITAF. Little is known about the
orientation of LITAF in vesicles. The PPXY motifs of LITAF must
be in the same compartment as the WW domains of Itch so the two
proteins can interact in vivo. Since Itch is suspected to be a cytosolic
protein associated with internal membranes, we deduce that the N-
terminus of LITAF, containing the PPXY motif, must also be found
inthecytosol. Ifthehydrophobic stretchof aminoacids found inthe
SLD of LITAF act as a transmembrane domain than the C-
terminus of LITAF may be found on the luminal side of
endosomes/lysosomes. Future studies will further explore the
orientation of LITAF in vesicle membranes.
Itchand Nedd4arestructurallysimilarproteinsthataremembers
of a conserved family of HECT ubiquitin ligases. Both contain an
N-terminal C2 domain that may play a role in membrane targeting.
They both contain 4 WW domains that mediate interactions with
Figure 5. Mutation of both PPXY domains disrupts Itch and LITAF co-localization. (A) Site-directed mutagenesis was used to mutate the
two PPXY motifs (either individually or together) located in the N-terminus of GFP-LITAF. (B) Expression constructs containing each mutated GFP-
LITAF construct and FLAG-Itch were co-transfected into BGMK cells and 16 hours post-transfection, cells were incubated with LysoTracker (blue),
fixed, and processed by indirect immunofluorescence to detect Itch (anti-FLAG; green), LITAF (red), and the trans-Golgi network (anti-IGF-IIR; blue).
Cells were visualized using DIC.
doi:10.1371/journal.pone.0016873.g005
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responsible for E3 ligase activity. Furthermore, both Itch and
Nedd4interact with LITAF,atleastprimarilythroughLITAF’sfirst
PPXY motif. There are several possible explanations as to why
LITAF canmediatethe re-localization of Itch, butnot Nedd4. First,
given the high levels of structural similarities between Itch and
Nedd4, it suggests that functional differences between Nedd4 and
Itch are responsible for the different situations induced following an
interaction with LITAF. Another possibility is that the targeting
sequences of Nedd4 are ‘‘stronger’’ than the targeting sequences for
Itch. This would imply that although LITAF and Nedd4 can
interact, LITAF is not able to mediate the re-localization of Nedd4.
Finally, in vivo, LITAF and Nedd4 may not be present in the same
cellular compartments.If the twoproteins cannotphysicallyinteract
in vivo, then there is no possibility of LITAF mediating the re-
localization of Nedd4. Our immunofluorescence data suggests that
Nedd4 is found in the Golgi apparatus, but not in the trans-Golgi
network.Thismaymove Nedd4outofthe cycling pathwaybetween
the trans Golgi network/endosome/lysosome compartments pre-
cluding it from interacting with LITAF.
Since the function of LITAF remains unknown, we can only
speculate on the consequences that the re-localization of Itch has
Figure 6. LITAF does not alter the cellular localization of Nedd4. YFP-Nedd4 was transiently transfected into BGMK cells either alone, with
myc-LITAF WT, or myc-LITAF Y23,61A. Cells were fixed and immunofluorescence was completed to visualize WT LITAF or LITAF Y23,61A (anti-myc:
red), Nedd4 (green), lysosomes (LysoTracker; blue) and the Golgi apparatus (anti-Golgin; blue). Cells were visualized using DIC.
doi:10.1371/journal.pone.0016873.g006
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Golgi network to the lysosomes with the assistance of LITAF.
LITAF and Itch may form a stable complex that translocates to
the lysosome where Itch may or may not dissociate from LITAF
within the lysosome for future degradation. It is also possible that
LITAF retains Itch in the late endosomes/lysosomes. Itch has
been found to localize within both endosomes and the trans-Golgi
network [26]. The presence of LITAF may limit movement of Itch
and retain Itch within the late endosomes. LITAF may sequester
Itch to limit the ability of Itch to target proteins for degradation or
to protect the cell from the putative harmful effects of Itch through
its degradation. Interestingly, ubiquitination of Jun by Itch has
been shown to trigger Jun accumulation to the lysosomal
compartment, by a still unknown mechanism [27]. The LITAF
and Itch interaction could thus be a targeting mechanism to bring
Itch substrates to the lysosome.
Binding of small PPXY motif-containing proteins to Itch may
also impact its activity. Ndfip1 and Ndfip2 binding have been
shown to stimulate the ubiquitin ligase activity of both Itch and
Nedd4 [30,31]. Conversely, N4BP1 strongly inhibits Itch-cata-
lyzed polyubiquitination of several proteins by preventing the
interaction between the ligase and its substrates, thereby reducing
the transfer of ubiquitin molecules to Itch protein targets [32].
On the other hand, due to the fact that Itch is an E3 ubiquitin
ligase, the possibility exists that Itch re-localizes to or remains in
late endosomes where it interacts with LITAF and mediates the
transfer of ubiquitin to LITAF for future degradation. LITAF may
represent another substrate of Itch and Itch may function to
regulate cellular levels of LITAF by targeting it for degradation in
the lysosome. Further studies will be important to elucidate the
consequences of the novel interaction between LITAF and Itch.
Materials and Methods
Reagents, cell lines, and antibodies
Babygreen monkey kidney (BGMK) cells were obtained from the
American Type Culture Collection (ATCC; Manassas, VA) and
were maintained at 37uC with 5% CO2 in Dulbecco’s modified
Eagle’s medium (DMEM; HyClone, Ottawa, ON) supplemented
with 7% FBS, 2 mM L-glutamine, penicillin (100 U/mL), and
streptomycin (100 mg/mL). Human embryonic kidney (HEK)-
293T cells for immunoprecipitation, pull-down assays and BRET
experimentswereobtained from the ATCCandweremaintained at
37uC with 5% CO2 in high glucose DMEM (Gibco products,
Invitrogen, Grand Island, NY) supplemented with 10% cosmic calf
serum (HyClone, Ottawa, ON), penicillin (Invitrogen, Burlington,
ON; 100 U/mL) and streptomycin (Invitrogen, Burlington, ON;
100 mg/mL). All cells used for immunoprecipitation and pull-down
assays were transfected with the indicated plasmids using calcium/
phosphate [33] and 5 mg plasmid/10 cm
2 plate. Cells used for
immunofluorescence were transfected using a polyethylenimine
(PEI) reagent using 5 mg plasmid/10 cm
2 plate and a PEI:DNA
ratio of 4:1. Antibodies used during immunofluorescence include:
9E10 myc monoclonal antibody obtained from Roche (dilution - 1/
100; Indianapolis, IN); monoclonal antibody against FLAG (M2)
from Sigma (dilution - 1/500; Oakville, ON); anti-IGF-IIR from
Santa Cruz Biotechnology (dilution – 1/50; Santa Cruz, CA);
FITC/Cy3/Cy5-conjugated goat anti-mouse or anti-rabbit immu-
noglobulin G (IgG) from Jackson ImmunoResearch Inc. (dilutions –
1/100, 1/200, 1/100 respectively; West Grove, PA); anti-Golgin 97
antibody from Invitrogen (dilution – 1/100; Burlington, ON); and
LysoTracker
TMDND-99 from Molecular Probes (Burlington, ON).
Antibodies used during immunoprecipitations and pull-down assays
include: monoclonal antibody against c-myc clone 9E10 obtained
from Enzo Life Sciences (dilution 1:1000; Farmingdale, NY);
monoclonal antibody against FLAG (M2) from Sigma (dilution - 1/
1000); and polyclonal anti-GFP from Invitrogen (dilution 1/5000).
Expression plasmids
LITAF (wild-type; WT) expression plasmids containing N-
terminus FLAG or myc tags were generated by PCR and cloned
into the XhoI and HindIII restriction sites of the plasmid
pcDNA3.1-A (Invitrogen) using mouse LITAF cDNA (MGC-
6569, ATCC) as template DNA and the following primers: 59-
AAGCTTA TGGATTACAAGGATGACGACGATAAGTCG-
GTTCCAGGACCTTACC-39 (F – FLAG), 59-AAGCTTATG-
GAACAAAAAGTTATTTCTGAAGAAGATCTGTCGGTTC-
CAGGAC CTTACC-39 (F–myc), 59-CTCGAGCTAAAAGC-
GTTGTAGGTG-39 (R). An LITAF WT expression plasmid
containing N-terminus GFP tag was generated by PCR and cloned
into the XhoI and HindIII restriction sites of the plasmid pEGFP-
C2 (Clontech, Mountain view, CA) using myc-LITAF as template
DNA and the following primers: forward 59-GAGACTCGA-
GAATGTCGGTTCCAGGACC-39 and reverse 59-GAGAAA-
GCTTCTACAAACGCTTGTAGGTG-39. The resulting GFP-
LITAF plasmid was used as a template to make the 3 LITAF
mutants Y23A, Y61A or Y23,61A using a QuikChangeH
Lightning Multi Site-Directed Mutagenesis Kit (Stratagene, La
Jolla, CA) according to the manufacturer’s instructions and with
the following primers: Y23A 59-CCACCCCCAACCGCTGAA-
GAAACAGTG-39 and Y61A 59-GAATCCACCTTCGG
CCTACACCCAGCC-39. A myc tagged N-terminal LITAF
Y23,61A construct was created through amplification of LITAF
Y23,61A from the GFP-LITAF Y23,61A template DNA using 59-
AAGCTTATGGAACAAAAAGTTATTTCTGAAGAAGAT C-
TGTCGGTTCCAGGACCTTACC-39 as the forward primer
and 59-CTCGAGCTA AAAGCGTTGTAGGTG-3; as the
reverse primer. It was cloned into pcDNA3.1-A (Invitrogen) using
the restriction sites XhoI and HindIII. FLAG (pFlag-CMV2) or
GST (pGEX-4T-1) tagged Itch (WT), Itch’s PRD domains or WW
domains have been described previously [26,28]. Itch sequence
was amplified by PCR from FLAG-Itch WT using forward
59GAGAGGTAC CAATGGGTAGCCTCACCATG-39and re-
verse 59- GAGAGGATCCTTACTCTTGTC CAAATCCTTC-
39. The resulting PCR product was subcloned into the BamHI and
KpnI restriction sites of the plasmid pRluc-C1 (BioSignal Packard,
Montreal, QC). YFP-Nedd4 was a kind gift from Paul D. Bieniasz
(Aaron Diamond AIDS Research Center and The Rockefeller
University, New York, USA).
Immunoprecipitation and pull-down assays
Dishes (10 cm) of transfected HEK-293T cells were washed in
phosphate buffer saline (PBS) and resuspended in 1 mL buffer A
(20 mM Hepes, pH 7.4, 150 mM NaCl) plus protease inhibitors.
The cells were lysed by sonication and Triton X-100 was added to
a final concentration of 1%. Extracts were incubated for 20
minutes at 4uC and centrifuged at 45 000 rpm in an
ultracentrifuge at 4uC. For immunoprecipitation assays, extracts
of transfected cells were immunoprecipitated using protein A–
Sepharose beads and antibodies against the target proteins for
16 hours at 4uC. Beads were washed extensively with buffer A/1%
Triton X-100 and prepared for western blot analysis. For pull-
down assays, extracts were incubated with 20 mg of the
appropriate GST-fusion protein coupled with glutathione Sephar-
ose 4B (Bio-World, Dublin, OH) for 16 hours at 4uC. Beads were
washed extensively in the same buffer and prepared for western
blot analysis. In an effort to normalize the quantity of GST-fusion
proteins used in each assay, purified beads were run on a 10%
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of BSA. The gel was stained with Coomassie and densitometry
analysis allowed us to determine the approximate volume of beads
needed to obtain the desired amount of GST-fusion. Due to heavy
degradation, the ful-length GST-Itch fusion was particularly hard
to estimate since the binding region might be present on several
bands visible by Coomassie, Ponceau and anti-GST staining. We
therefore considered only the highest molecular weight band
intensity in our calculations, which is likely an overestimate.
Western blot analysis
Protein extracts and purified proteins obtained by immunopre-
cipitation or pull-down assays were separated by SDS-PAGE on
5–16% polyacrylamide gels. Proteins were then transferred to
nitrocellulose for blotting with the appropriate primary and
secondary antibodies. 0.1 mg/ml of goat anti-rabbit-HRP conju-
gated antibody or goat anti-mouse-HRP conjugated IgG were
used (Jackson ImmunoResearch Laboratories, West Grove, PA).
Antibody incubation and membrane washing were performed in
PBS supplemented with 5% dry milk and 0.05% Tween 20.
Immunoreactivity was detected by chemiluminescence using
West-Pico SuperSignal (Thermo Fisher Scientific, Ottawa, ON).
Quantification of pull-down assays
To quantitatively compare the interaction between Itch and the
different LITAF mutants, we used 20 mg of purified GST-Itch-WW
coupled to glutathione Sepharose 4B, incubated with 1 mL of protein
extracts obtained from HEK-293T cells transfected with GFP-
LITAF WT, GFP-LITAF Y23A, GFP-LITAF Y61A or GFP-LITAF
Y23,61A. The relative binding of LITAF to Itch is obtained by
measuring the ratio of the densitometry of the GFP proteins bound to
beads as compared to the signal obtained with 1/10 volume of total
protein extract. The densitometry measurements were performed in
Photoshop CS5 (Adobe Systems Incorporated, San Jose, CA). For
statistical comparison, one-way analysis of variance followed by
Tukey’s test was employed using SPSS software (SPSS Inc., Chicago,
IL). p-values smaller than 0.05 were considered to be statistically
significant. Data are represented as mean 6 s.e.m.
BRET experiments
For BRET analysis, HEK-293T cells (2610
6) were co-
transfected with cDNAs coding for rLuc–Itch and different GFP
fusion proteins. Forty hours post-transfection, the cells were
washed in PBS, collected in 1 mL Tyrode’s solution, and then
diluted to 10
6 cells/mL). Coelenterazine (Biotium, Hayward, CA,
USA) was added at a final concentration of 5 mM. Total
fluorescence was measured in a FlexStation apparatus (Molecular
Devices, Sunnyvale, CA, USA). Luminescence and fluorescence
were quantitated with a Mithras LB 940 apparatus (Berthold
Technologies, Oak Ridge, TN, USA). Three measures were
obtained: first, light emitted at 485620 nm by rLuc; second,
emission of fluorescence at 530625 nm with excitation due to
energy transfer from rLuc to GFP; third, emission fluorescence at
530 nm after excitation at 485 nm to measure total expression of
GFP fusion proteins. The BRET ratio was defined as [(emission at
510–590 nm) – (emission at 440–500 nm)6Cf]/(emission at 440–
500 nm), where Cf corresponds to (emission at 510–590 nm)/
(emission at 440–500 nm) for rLuc-fused Itch expressed alone in
the same experiments [34].
Immunofluorescence analysis
Approximately 16–24 hours post-transfection cells were fixed
for ten minutes in 3.7% paraformaldehyde in PBS. Cells were
washed several times in PBS and were permeabilized in a 0.1%
Triton X-100 in PBS solution for four minutes. Following several
washes in PBS, cells were blocked for two hours at room
temperature in block buffer (5% BSA (w/v), 50 mM Tris HCl
(pH 7.4), 150 mM NaCl, 0.5% NP-40 (v/v). Cells were then
washed several times with wash buffer (1% BSA (w/v), 50 mM
Tris HCl (pH 7.4), 150 mM NaCl, 0.5% NP-40 (v/v)) and were
incubated for one hour at room temperature with primary
antibody diluted in wash buffer. Cells were washed several times
in wash buffer and incubated for one hour at room temperature in
darkness with secondary antibody diluted in wash buffer.
Following several more washes in wash buffer, fluorescence was
detected using a Leica DM SP2 confocal microscope (Leica,
Wetzlar, Germany) and images were assembled using Adobe
Photoshop CS4 (Adobe, San Jose, CA).
Supporting Information
Figure S1 LITAF-WT alters endogenous Itch localization in
different cell lines. GFP-LITAF-WT or GFP-LITAF-Y23,61A
(green) was transiently transfected in Cos-7 (A), HEK-293T (B) or
PAE (C) cells. After lysotracker uptake (blue), cells were fixed and
immunofluorescence performed to visualize Itch protein (red).
(TIF)
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